Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Price & Analysis

8 Followers

BJTRF Stock Chart & Stats

$0.65

$0.00(0.00%)

At close: Apr 01 4:00 PM EDT

$0.65

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.65 - $0.65

Previous CloseN/A

Volume30.00

Average Volume (3M)0.00

Market Cap

$736.69M

Enterprise Value$3.44B

Total Cash (Recent Filing)$2.28B

Total Debt (Recent Filing)$126.54M

Price to Earnings (P/E)14.6

Beta0.00

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield7.32%

Share Statistics

EPS (TTM)0.47

Shares Outstanding837,100,000

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-0.83

Price to Book (P/B)1.69

Price to Sales (P/S)4.68

P/FCF Ratio8.56

Enterprise Value/Market Cap4.67

Enterprise Value/Revenue2.27

Enterprise Value/Gross Profit3.72

Enterprise Value/Ebitda6.94

Forecast

1Y Price Target

$1.34

Price Target Upside106.09% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)0.08

Revenue Forecast (FY)$213.62M

Bulls Say, Bears Say

Bulls Say

Very Low LeverageA debt-to-equity around 0.03 indicates a conservatively financed business that can absorb shocks, fund retail expansion or product investment, and maintain dividends without refinancing stress. That balance-sheet flexibility supports durable operations and strategic optionality over months.

High And Stable MarginsConsistently strong gross and operating margins provide durable earnings power that supports reinvestment, R&D, and shareholder payouts. Healthy margins help the company withstand price competition and facilitate margin-accretive product mix shifts over a multi-month horizon.

Diversified Channels & Strong BrandA multi-channel model—manufacturing, wholesale distribution and branded retail—plus the Tong Ren Tang brand provide durable revenue diversification, pricing power, and direct consumer access. This structural mix reduces single-channel risk and supports steady cash generation.

Bears Say

Recent Revenue DeclineAn 11.4% revenue decline in 2025 signals weakening demand, pricing or mix shifts that impair scale economics. If the top-line contraction persists, it can erode operating leverage and compress margins, forcing tougher trade-offs on investment and dividends over the medium term.

Falling Return On EquityROE erosion to roughly 9.5% reflects weaker returns on the company's capital base, reducing capital efficiency. Lower ROE over several years can limit shareholder value creation, constrain reinvestment returns and indicate structural margin or competitive pressure risks ahead.

Cash-flow VolatilityIntermittent negative OCF/FCF (notably 2024) signals working-capital swings and uneven cash conversion despite profits. This volatility hurts predictability for capex, dividends, and store investment and raises reliance on the balance sheet to smooth operations in tighter periods.

Beijing Tong Ren Tang Chinese Medicine Co News

Beijing Tong Ren Tang Chinese Medicine Shifts to New Product Sales Framework with Controlling Shareholder

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) just unveiled an announcement. Beijing Tong Ren Tang...

21d ago

Beijing Tong Ren Tang Chinese Medicine Wins Strong Shareholder Backing at AGM

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) just unveiled an update. Beijing Tong Ren Tang...

1M ago

Beijing Tong Ren Tang Chinese Medicine Wins Hong Kong Approval for New Capsule Product

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) just unveiled an update. Beijing Tong Ren Tang...

2M ago

Beijing Tong Ren Tang Chinese Medicine Sets 2026 AGM, Proposes Dividends and Share Issue Mandate

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) has provided an announcement. Beijing Tong Ren Tang...

3M ago

Beijing Tong Ren Tang Chinese Medicine Flags Q1 2026 Results Releases by Parent Companies

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) has shared an update. Beijing Tong Ren Tang...

3M ago

Beijing Tong Ren Tang Chinese Medicine Wins Macau Approval for New Remedy

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) has issued an update. Beijing Tong Ren Tang...

3M ago

Beijing Tong Ren Tang Chinese Medicine Declares Special Dividend for 2025

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) has issued an update. Beijing Tong Ren Tang...

4M ago

Beijing Tong Ren Tang Chinese Medicine Profit Falls but Dividends Raised on Strong Cash Position

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) has issued an update. Beijing Tong Ren Tang...

4M ago

Beijing Tong Ren Tang Chinese Medicine Sets HKD 0.37 Final Dividend for 2025

An update from Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) is now available. Beijing Tong...

4M ago

Beijing Tong Ren Tang Chinese Medicine Sets March Board Meeting on 2025 Results and Dividend

Beijing Tong Ren Tang Chinese Medicine Co ( ($HK:3613) ) just unveiled an announcement. Beijing Tong Ren Tang...

5M ago

BJTRF FAQ

What was Beijing Tong Ren Tang Chinese Medicine Co Ltd’s price range in the past 12 months?

Beijing Tong Ren Tang Chinese Medicine Co Ltd lowest stock price was $0.65 and its highest was $0.65 in the past 12 months.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd’s market cap?

Beijing Tong Ren Tang Chinese Medicine Co Ltd’s market cap is $736.69M.

When is Beijing Tong Ren Tang Chinese Medicine Co Ltd’s upcoming earnings report date?

Beijing Tong Ren Tang Chinese Medicine Co Ltd’s upcoming earnings report date is Aug 07, 2026 which is in 18 days.

How were Beijing Tong Ren Tang Chinese Medicine Co Ltd’s earnings last quarter?

Beijing Tong Ren Tang Chinese Medicine Co Ltd released its earnings results on Mar 20, 2026. The company reported $0.025 earnings per share for the quarter, beating the consensus estimate of N/A by $0.025.

Is Beijing Tong Ren Tang Chinese Medicine Co Ltd overvalued?

According to Wall Street analysts Beijing Tong Ren Tang Chinese Medicine Co Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Beijing Tong Ren Tang Chinese Medicine Co Ltd pay dividends?

Beijing Tong Ren Tang Chinese Medicine Co Ltd pays a Annually dividend of $0.051 which represents an annual dividend yield of 7.32%. See more information on Beijing Tong Ren Tang Chinese Medicine Co Ltd dividends here

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd’s EPS estimate?

Beijing Tong Ren Tang Chinese Medicine Co Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Beijing Tong Ren Tang Chinese Medicine Co Ltd have?

Beijing Tong Ren Tang Chinese Medicine Co Ltd has 837,100,000 shares outstanding.

What happened to Beijing Tong Ren Tang Chinese Medicine Co Ltd’s price movement after its last earnings report?

Beijing Tong Ren Tang Chinese Medicine Co Ltd reported an EPS of $0.025 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Beijing Tong Ren Tang Chinese Medicine Co Ltd?

Currently, no hedge funds are holding shares in BJTRF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.

Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Earnings & Revenues

Historic Earnings Reports

BJTRF Stock 12 Month Forecast

Average Price Target

$1.34

▲(106.09% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","-1":"-$1","-0.25":"-$0.25","0.5":"$0.5","1.25":"$1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.3395585,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.3395585,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.3395585,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.648,0.7011968076923077,0.7543936153846154,0.8075904230769231,0.8607872307692308,0.9139840384615385,0.9671808461538463,1.020377653846154,1.0735744615384615,1.1267712692307694,1.179968076923077,1.2331648846153846,1.2863616923076924,{"y":1.3395585,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.648,0.7011968076923077,0.7543936153846154,0.8075904230769231,0.8607872307692308,0.9139840384615385,0.9671808461538463,1.020377653846154,1.0735744615384615,1.1267712692307694,1.179968076923077,1.2331648846153846,1.2863616923076924,{"y":1.3395585,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.648,0.7011968076923077,0.7543936153846154,0.8075904230769231,0.8607872307692308,0.9139840384615385,0.9671808461538463,1.020377653846154,1.0735744615384615,1.1267712692307694,1.179968076923077,1.2331648846153846,1.2863616923076924,{"y":1.3395585,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.597,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.597,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.648,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >